Omicron News and Research

RSS
Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2

18 Apr 2022
Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

18 Apr 2022
Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

18 Apr 2022
Monoclonal antibodies from COVID-19 convalescent donors target conserved site

Monoclonal antibodies from COVID-19 convalescent donors target conserved site

18 Apr 2022
RNA interference triggers that target SARS-CoV-2 genome

RNA interference triggers that target SARS-CoV-2 genome

18 Apr 2022
SARS-CoV-2 infection patterns in olfactory epithelium

SARS-CoV-2 infection patterns in olfactory epithelium

18 Apr 2022
Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

18 Apr 2022
Durable neutralizing response against Omicron after heterologous vaccine boosting

Durable neutralizing response against Omicron after heterologous vaccine boosting

15 Apr 2022
Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

15 Apr 2022
Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

15 Apr 2022
Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

14 Apr 2022
Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

14 Apr 2022
People with COVID-19 can shed viral RNA in their feces months after initial infection

People with COVID-19 can shed viral RNA in their feces months after initial infection

13 Apr 2022
CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

13 Apr 2022
Impact of COVID-19 infection and vaccination on antibody response

Impact of COVID-19 infection and vaccination on antibody response

13 Apr 2022
The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

13 Apr 2022
SARS-CoV-2 spreads extensively in households, with children being an important source of spread

SARS-CoV-2 spreads extensively in households, with children being an important source of spread

13 Apr 2022
Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

13 Apr 2022
mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

12 Apr 2022
Comparing SARS-CoV-2 Delta and Omicron waves in Germany

Comparing SARS-CoV-2 Delta and Omicron waves in Germany

12 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback